Back to funds

AlphaCentric Advisors LLC

Updated 2 days ago

Managed by Alphacentric Advisors Llc • Latest filing Q3 2026

Portfolio value
$112.6M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$100.3M
Q1 2026$100.1M
Q2 2026$118M
Q3 2026$112.6M

Top holdings

247 positions as of Q3 2026

View filing
B

ISHARES TR

Value
$5.4M
Shares
66.0K
% Port
4.76%
G

GILEAD SCIENCES INC

Value
$3.2M
Shares
21.3K
% Port
2.82%
E

ISHARES TR

Value
$3M
Shares
12.0K
% Port
2.65%
I

INVESCO EXCHANGE TRADED FD T

Value
$2.9M
Shares
25.4K
% Port
2.59%
V

VERTEX PHARMACEUTICALS INC

Value
$2.7M
Shares
5.1K
% Port
2.37%
I

INVITATION HOMES INC

Value
$1.9M
Shares
73.0K
% Port
1.71%
A

ASTRAZENECA PLC

Value
$1.9M
Shares
11.9K
% Port
1.70%
R

ROIVANT SCIENCES LTD

Value
$1.8M
Shares
50.5K
% Port
1.64%
I

INCYTE CORP

Value
$1.8M
Shares
15.1K
% Port
1.63%
A

ARGENX SE

Value
$1.8M
Shares
1.8K
% Port
1.57%
N

NEUROCRINE BIOSCIENCES INC

Value
$1.5M
Shares
10.2K
% Port
1.29%
E

EURONET WORLDWIDE INC

Value
$1.4M
Shares
21.6K
% Port
1.20%
P

PROTAGONIST THERAPEUTICS INC

Value
$1.4M
Shares
9.6K
% Port
1.20%
I

INSMED INC

Value
$1.4M
Shares
11.9K
% Port
1.20%
P

ALPINE INCOME PPTY TR INC

Value
$1.3M
Shares
75.0K
% Port
1.16%
B

BUILDERS FIRSTSOURCE INC

Value
$1.3M
Shares
22.5K
% Port
1.14%
A

AXSOME THERAPEUTICS INC.

Value
$1.2M
Shares
6.8K
% Port
1.11%
J

JAZZ PHARMACEUTICALS PLC

Value
$1.1M
Shares
4.7K
% Port
0.96%
H

HALOZYME THERAPEUTICS INC

Value
$1.1M
Shares
9.8K
% Port
0.96%
A

ASCENDIS PHARMA A/S

Value
$1.1M
Shares
4.7K
% Port
0.95%

Explore

AlphaCentric Advisors LLC (Alphacentric Advisors Llc) Portfolio & 13F Holdings | Track13F